Volume 4, Issue 2, Page 8 (February 2008)
9 of 37
PREVIEW
FULL TEXT
FULL-TEXT PDF (58 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
DOWNLOAD IMAGES
NEED REPRINTS?
BOOKMARK ARTICLE
SAN ANTONIO — Gabapentin failed to demonstrate any benefit for chemotherapy-induced neuropathy in the sole rigorous study done to date, Dr. Charles L. Loprinzi said at the San Antonio Breast Cancer Symposium.
PII: S1553-3212(08)70067-0
doi:10.1016/S1553-3212(08)70067-0
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.